Shiv Rao, MD, is the co-founder and CEO of Abridge, the healthcare AI company last valued at a reported $5.3 billion (June 2025). A practicing cardiologist at UPMC, he started it in February 2018. He doesn’t publish a personal email address; his public channels are LinkedIn and X, and Abridge’s media inbox is press@abridge.com.
Shiv Rao at a glance
Fact | Detail |
|---|---|
Full name | Shivdev (Shiv) Rao, MD |
Role | Co-founder and CEO of Abridge since 2018 |
Also | Practicing cardiologist at UPMC |
Education | BA, Carnegie Mellon; medical education and training at the University of Michigan and the University of Pittsburgh School of Medicine |
Based in | Pittsburgh, commuting to San Francisco |
Age | Not published by a reliable source |
Net worth | No Forbes or Bloomberg estimate |
Not published; press@abridge.com for media | |
linkedin.com/in/shivdevrao | |
X | @ShivdevRao |
Abridge CEO email address: how to reach Shiv Rao
Rao doesn’t publish a personal email address, and Abridge doesn’t publish one for him. He is on LinkedIn, with about 19,000 followers, and on X. Abridge’s official inboxes are below.
Channel | Address | Note |
|---|---|---|
linkedin.com/in/shivdevrao | About 19,000 followers | |
X | @ShivdevRao | About 4,000 followers |
Press | press@abridge.com | Abridge’s media inbox |
Sales | sales@abridge.com | Sales inquiries |
Privacy | privacy@abridge.com | Privacy and data requests |
Website | abridge.com/contact | Contact form |
Need verified CEO emails at scale? The LeadWave AI companies email list has verified emails of the CEOs and founders of 9,000+ AI companies.
Shiv Rao’s career timeline
Date | Milestone |
|---|---|
Sep 2026 | Abridge selected under the VA enterprise contract |
Jun 2026 | Launches the clinician intelligence platform; Eli Lilly invests |
Jun 2025 | Raises a $300M Series E at a reported $5.3B |
Feb 2025 | Raises a $250M Series D at $2.75B |
Feb 2024 | Raises a $150M Series C at $850M |
Aug 2023 | Abridge becomes the first Pal in Epic’s partner program |
Aug 2022 | Takes Abridge to health systems with an enterprise product |
Oct 2020 | Launches Abridge publicly as an app for patients |
2019 | Pitches Union Square Ventures, which leads a $5M seed |
Feb 2018 | Starts Abridge with Sandeep Konam |
Before Abridge | Cardiologist at UPMC, where he also led the provider-facing investment portfolio |
How Shiv Rao built Abridge
Rao is the son of a Pittsburgh physician. He spent five years of his childhood in Hyderabad, India, then came back to Pittsburgh. Years before Abridge he helped in his father’s cardiology clinic: “I was going into Mercy Hospital in downtown Pittsburgh and just basically being his scribe,” he said in a 2026 talk. He majored in history at Carnegie Mellon before turning to medicine.
As a UPMC cardiologist he spent half his time as a corporate venture capitalist for the health system, and he helped fund a machine learning program at Carnegie Mellon. The paperwork was the problem he wanted to fix: “I became a cardiologist to help my patients improve their health, but the reality was that I was spending more time on my notes than with my patients,” he said in 2022.
He started Abridge with Konam in February 2018. In 2019 he pitched Union Square Ventures on what he called “SoundCloud plus RapGenius for medicine”. The first product, launched in October 2020, helped patients remember their appointments. By 2022 Abridge was selling to health systems, and it went from more than 100 of them in February 2025 to more than 300 by June 2026.
Is Shiv Rao still a doctor?
Yes. Abridge still describes him as a practicing cardiologist, and he told an interviewer in May 2026 that he sees patients one week a month.
Shiv Rao’s education
He earned a BA at Carnegie Mellon, where he majored in history, and completed his medical education and training at the University of Michigan and the University of Pittsburgh School of Medicine.
Shiv Rao’s net worth and age
Forbes and Bloomberg haven’t published a net worth estimate for Rao, and his stake in Abridge isn’t public, so we don’t give a figure. No reliable source publishes his age or year of birth.
In his own words
“We have 100% full control, and that’s super important to me.”
— Shiv Rao on Abridge’s investors, May 2026
“If we can’t actually improve how healthcare is delivered, how it’s experienced, and how it’s paid for, then we haven’t really moved the needle on the problem.”
— Shiv Rao to Fortune, June 2026
“I actually think AI is underhyped.”
— Shiv Rao, May 2026
“Pressure makes diamonds.”
— Shiv Rao on competition from Epic, May 2026
Abridge’s leadership
Person | Role |
|---|---|
Shiv Rao, MD | Co-founder and CEO; practicing cardiologist at UPMC |
San Oo | Named chief technology officer in May 2026; previously at Slack and Notion |
Sagar Sanghvi | Named Abridge’s first chief financial officer in January 2025 |
Zachary Lipton | Joined as chief scientific officer in February 2023 from Carnegie Mellon and Amazon AI |
Tim Hwang | Named general counsel in August 2024 |
Tina Shah, MD | Named chief clinical officer in September 2023 |
More on Abridge
Abridge company profile: revenue, valuation, funding, customers and rivals
Healthcare SaaS companies: software for providers, payers and patients
List of SaaS unicorns: private software companies worth $1B or more
AI companies email list: verified emails of AI company CEOs and founders







